Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Brown vs TPL Motion in Limine

I hope I am wrong too but forgive me if I remain skeptical given the history of abuse. Perhaps you might be able to explain to me why PTSC in past SEC filings used the equity method of accounting for PDS and explained that this gave Patriot some influence (but not control over) PDS. In the most recent filing, it changed it's method of accounting.

I am not an accountant but I would like to know if the change in accounting method gives PTSC more or less influence and some or no control over PDS.

Share
New Message
Please login to post a reply